Latest News
Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals Inc. Estimates – GETTEX:VM4
- Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026
- Vanda Pharmaceuticals’ VQW-765 misses primary endpoint
- Vanda pauses social anxiety program after ex-Novartis asset flunks phase 3 study
- Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
- Vanda Pharmaceuticals Mallorca Women's Championships 2026 Scores | Latest Scores & Live Updates – WTA Official
- Vanda Pharmaceuticals Announces Presentation at 2026 EADV Annual Meeting
- Vanda Pharmaceuticals Athens Open 2027 Scores | Latest Scores & Live Updates – WTA Official
- Vanda lines up new expansion prospect for Hetlioz as FDA jet lag hearing looms
- Why is Vanda Pharmaceuticals stock surging today?
- Vanda Pharmaceuticals Announces Positive Phase III Results For Hetlioz®(Tasimelteon) In Delayed Sleep-Wake Phase Disorder
- Vanda Pharmaceuticals Announces Positive Phase III Results for HETLIOZ®(tasimelteon) in Delayed Sleep-Wake Phase Disorder
Headlines from the last 30 days, linking to the original publishers. See all market news →